Thursday, 01 October 2020


ProMetic to get $10 mn equity from Chinese firm

10 January 2013 | News | By BioSpectrum Bureau

ProMetic Life Sciences to get has $10 million strategic equity investment from Shenzhen Hepalink Pharma

ProMetic Life Sciences to get has $10 million strategic equity investment from Shenzhen Hepalink Pharma

Singapore: ProMetic Life Sciences has finalized the $10 million strategic equity investment by Shenzhen Hepalink Pharmaceutical pursuant to the terms and conditions previously disclosed on October 16, 2012.

Mr Pierre Laurin, president and CEO, ProMetic, said that, "The funds received will enable the execution of various strategic initiatives, including the 2013 operational launch of ProMetic's GMP plasma facility, located in Laval, Quebec in Canada, and dedicated to the manufacturing of plasma derived products." 


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account